Study oversight
The IB1001-301 trial is conducted in accordance with the International Conference for Harmonisation (of Technical Requirements for Pharmaceuticals for Human Use)—Good Clinical Practice Guideline, the General Data Protection Regulator, and the Declaration of Helsinki. The study protocol was designed in accordance with the SPIRIT 2013 statement and the study is conducted in accordance with the SPIRIT reporting guidelines [